Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

RLAY Stock Annual Income Statement. Download in Excel

Relay Therapeutics Inc. logo

Relay Therapeutics Inc.

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

4.16
 
USD
  
-0.10
  
(-2.35%)
Previous close: 4.26  Open: 4.2  Bid: 4.2  Ask: 4.25
52 week range    
4.11   
   12.14
Mkt Cap: 753 M  Avg Vol (90 Days): 1,899,167
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Sunday 22nd December 2024

Stock Rankings

46
MarketXLS Rank
60
Value
46
Technical
34
Quality
How are these ranks calculated?
Search for a stock

Financials

RLAY Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22Dec-23
AccruedPreferredStockDividends178 M
Basic EPS from continuing operations-5.4-3.82-2.59-2.79
Basic EPS total-5.4-3.82-2.59-2.79
Basic weighted shares outstanding43 M95 M112 M123 M
Depreciation4 M4 M4 M5 M
DepreciationAndAmortization4 M4 M4 M5 M
Diluted EPS total-5.4-3.82-2.59-2.79
Diluted normalized net income/share-2.59-2.79
Diluted weighted shares outstanding43 M112 M123 M
GeneralAndAdministrativeExpense39 M57 M66 M75 M
Gross operating profit83 M3 M1 M26 M
Income before tax-52 M-361 M-291 M-342 M
Interest income3 M830000.09 M31 M
InterestExpenseNonOperating12 M
MiscOtherSpecialCharges-16000.0-3 M-20000.0-18000.0
Net income from total operations-52 M-364 M-291 M-342 M
NetIncomeCommonStockholders-230 M-364 M-291 M-342 M
NetIncomeContinuousOperations-52 M-364 M-291 M-342 M
NetNonOperatingInterestIncomeExpense3 M-11 M9 M31 M
Operating income-56 M-365 M-299 M-373 M
Operating income before depreciation (EBITDA)-52 M-223 M-307 M-374 M
OperatingExpense138 M368 M312 M405 M
Other income net16000.04 M12 M6 M
OtherGandA39 M57 M66 M75 M
OtherOperatingExpenses4 M12 M6 M
OtherunderPreferredStockDividend178 M
PreferredStockDividends178 M
Research & development expense100 M296 M246 M330 M
ResearchExpense100 M296 M246 M330 M
Selling Gen & administrative expense39 M57 M66 M75 M
Total Income available for interest expense (EBIT)-56 M-227 M-311 M-379 M
Total common shares outstanding90 M108 M121 M131 M
Total net income-52 M-364 M-291 M-342 M
Total ordinary shares167 M167 M167 M167 M
Total revenues83 M3 M1 M26 M
TotalExpenses138 M368 M312 M405 M
TotalRevenue83 M3 M1 M26 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University